Pesquisas alternativas:
mtor complex » mediator complex (Expandir a Pesquisa)
complex cell » complex cells (Expandir a Pesquisa), complex case (Expandir a Pesquisa), complex care (Expandir a Pesquisa)
oil compact » oil company (Expandir a Pesquisa), oil contact (Expandir a Pesquisa), oil impact (Expandir a Pesquisa)
compact car » compact core (Expandir a Pesquisa), compact ag (Expandir a Pesquisa), compact air (Expandir a Pesquisa)
men newly » women newly (Expandir a Pesquisa), men new (Expandir a Pesquisa)
com men » com meu (Expandir a Pesquisa), com mel (Expandir a Pesquisa), com meg (Expandir a Pesquisa)
car non » ear non (Expandir a Pesquisa), war non (Expandir a Pesquisa), clear non (Expandir a Pesquisa)
5 mtor » 5p mtor (Expandir a Pesquisa), _ mtor (Expandir a Pesquisa), 1 mtor (Expandir a Pesquisa)
l com » l como (Expandir a Pesquisa), e com (Expandir a Pesquisa), l con (Expandir a Pesquisa)
3 oil » 3 oils (Expandir a Pesquisa), _ oil (Expandir a Pesquisa), l oil (Expandir a Pesquisa)
mtor complex » mediator complex (Expandir a Pesquisa)
complex cell » complex cells (Expandir a Pesquisa), complex case (Expandir a Pesquisa), complex care (Expandir a Pesquisa)
oil compact » oil company (Expandir a Pesquisa), oil contact (Expandir a Pesquisa), oil impact (Expandir a Pesquisa)
compact car » compact core (Expandir a Pesquisa), compact ag (Expandir a Pesquisa), compact air (Expandir a Pesquisa)
men newly » women newly (Expandir a Pesquisa), men new (Expandir a Pesquisa)
com men » com meu (Expandir a Pesquisa), com mel (Expandir a Pesquisa), com meg (Expandir a Pesquisa)
car non » ear non (Expandir a Pesquisa), war non (Expandir a Pesquisa), clear non (Expandir a Pesquisa)
5 mtor » 5p mtor (Expandir a Pesquisa), _ mtor (Expandir a Pesquisa), 1 mtor (Expandir a Pesquisa)
l com » l como (Expandir a Pesquisa), e com (Expandir a Pesquisa), l con (Expandir a Pesquisa)
3 oil » 3 oils (Expandir a Pesquisa), _ oil (Expandir a Pesquisa), l oil (Expandir a Pesquisa)
1
Por Diefenbach, Michael A, Benedict, Catherine, Miller, Suzanne M, Stanton, Annette L, Ropka, Mary E, Wen, Kuang-Yi, Fleisher, Linda G, Mohamed, Nihal E, Hall, Simon J
Publicado no Transl Behav Med (2018)
“...Men diagnosed with early stage prostate cancer face multiple treatment options, each...”Publicado no Transl Behav Med (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
“...OBJECTIVES: Describe dietary intake of participants enrolled in a non-prescriptive dietary...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
Por Hofstra, L. Marije, Sánchez Rivas, Elena, Nijhuis, Monique, Bank, Leonie E. A., Wilkinson, Eduan, Kelly, Karina, Mudrikova, Tania, Schuurman, Rob, de Oliveira, Tulio, de Kort, Jaclyn, Wensing, Annemarie M. J.
Publicado no Clin Infect Dis (2017)
“... individuals (54% of all newly diagnosed individuals in 2010–2015): 86% were men, 39% were foreign-born, and 22...”Publicado no Clin Infect Dis (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por Wetmore, Catherine M., Manhart, Lisa E., Lowens, M. Sylvan, Golden, Matthew R., Jensen, Nicole L., Astete, Sabina G., Whittington, William L. H., Totten, Patricia A.
Publicado em 2011
“...–6.7]; aOR(ED-control), 3.2 [95% CI, 1.3–7.6]; <5 vaginal partners: aOR(STD-control), 6.2 [95% CI, 1.8...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Por Maarten L. Donswijk, Pim J. van Leeuwen, Erik Vegt, Zing Cheung, Stijn W. T. P. J. Heijmink, Henk G. van der Poel, Marcel P. M. Stokkel
Publicado em 2020-08-01
“...). Methods Men with newly diagnosed biopsy-proven PCa who had been staged with a conventional staging...”Publicado em 2020-08-01
Obter o texto integral
Artigo
6
“... widely practiced in the United States for the past 20 years among heterogeneous groups of men. This has...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por Kessler, A F, Krause, K, Al-Shameri, B, Weiland, J, Linsenmann, T, Ernestus, R, Hagemann, C, Löhr, M, Jentschke, E
Publicado no Neuro Oncol (2018)
“... lower pQoL preferred to enter rehab, improving their SF-36 scores afterwards but again declined at T5...”Publicado no Neuro Oncol (2018)
Obter o texto integral
Obter o texto integral
Artigo
8
Por Pierce Campbell, Christine M., Viscidi, Raphael P., Torres, B. Nelson, Lin, Hui-Yi, Fulp, William, Abrahamsen, Martha, Lazcano-Ponce, Eduardo, Villa, Luisa L., Kreimer, Aimée R., Giuliano, Anna R.
Publicado no J Infect Dis (2016)
“...The role of antibody-mediated immunity in preventing newly acquired oral human papillomavirus (HPV...”Publicado no J Infect Dis (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Steven Gresswell, MD, Rodney E. Wegner, MD, Day Werts, PhD, Ralph Miller, MD, Russell Fuhrer, MD
Publicado em 2016-10-01
“...). The median nadir prostate-specific antigen was 0.5 ng/mL and time to nadir was 16 months. There was 1...”Publicado em 2016-10-01
Obter o texto integral
Artigo
10
Por Bhakti Hansoti, George Mwinnyaa, Elizabeth Hahn, Aditi Rao, John Black, Victoria Chen, Kathryn Clark, William Clarke, Anna L. Eisenberg, Reinaldo Fernandez, Joshua Iruedo, Oliver Laeyendecker, Roshen Maharaj, Pamela Mda, Jernelle Miller, Nomzamo Mvandaba, Yandisa Nyanisa, Steven J. Reynolds, Andrew D. Redd, Sofia Ryan, David F. Stead, Lee A. Wallis, Thomas C. Quinn
Publicado em 2019-10-01
“... was estimated at 4.5/100 person-years (95% CI: 2.4, 6.50) for women and 1.5 (CI 0.5, 2.5) for men. Of all HIV...”Publicado em 2019-10-01
Obter o texto integral
Artigo
11
Por Farmer, Charles, Yehia, Baligh R., Fleishman, John A., Rutstein, Richard, Mathews, W. Christopher, Nijhawan, Ank, Moore, Richard D., Gebo, Kelly A., Agwu, Allison L.
Publicado no J Pediatric Infect Dis Soc (2016)
“...]), and receiving care at a pediatric site (AOR, 5.37 [95% CI, 3.20–9.01]). Retention in years 2 and 3...”Publicado no J Pediatric Infect Dis Soc (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por MacPherson, Peter, Lalloo, David G, Choko, Augustine T, Mann, Gillian H, Squire, Stephen Bertel, Mwale, Daniel, Manda, Eddie, Makombe, Simon D, Desmond, Nicola, Heyderman, Robert, Corbett, Elizabeth L
Publicado em 2012
“... of clinic attendees undergoing HTC was lowest in non-pregnant women (6.3%) and men (8.5%), compared...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
Por Olga Siga*, Jarosαaw Królczyk, Anna Dzieża-Grudnik, Jolanta Walczewska, Barbara Wizner, Tomasz Grodzicki
Publicado em 2015-11-01
“...
N=32
Men, n[%]
12[39]
19[59]
Age[year]
45±10
44±12,5
BMI[kg/m2...”Publicado em 2015-11-01
Obter o texto integral
Artigo
14
Por Iffland, Philip H., Baybis, Marianna, Barnes, Allan E., Leventer, Richard J., Lockhart, Paul J., Crino, Peter B.
Publicado no Neurobiol Dis (2018)
“.../NPRL3 KD effects on cell size, filopodial extension, subcellular mTOR complex 1 (mTORC1) localization...”Publicado no Neurobiol Dis (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
“...Mammalian target of rapamycin (mTOR) is a key regulator in various cellular processes, including...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Por Dickson, Mark A., Schwartz, Gary K., Antonescu, Cristina R., Kwiatkowski, David J., Malinowska, Izabela A.
Publicado em 2012
“... of five consecutive patients with extrarenal non-pulmonary PEComas seen at one institution. Three complete...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Tsai, Te-Fu, Lin, Ji-Fan, Chou, Kuang-Yu, Lin, Yi-Chia, Chen, Hung-En, Hwang, Thomas I-Sheng
Publicado no Onco Targets Ther (2018)
“... of miR-99a-5p and the possible mechanism associated with mTOR in bladder cancer cells. MATERIALS...”Publicado no Onco Targets Ther (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
“... generally in the range of 5–15 μmol/l. In animal tumor models where the PI3K/AKT/mTOR pathway is abnormally...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por Tcherkezian, Joseph, Cargnello, Marie, Romeo, Yves, Huttlin, Edward L., Lavoie, Genevieve, Gygi, Steven P., Roux, Philippe P.
Publicado em 2014
“...The mammalian target of rapamycin (mTOR) promotes cell growth and proliferation by promoting mRNA...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
“...We have examined the role of the mammalian target of rapamycin (mTOR) in hepatic cell growth...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo